Last updated 4 months ago

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

350 patients around the world
Available in Spain, Brazil, Argentina, United States, Mexico
GlaxoSmithKline
350Patients around the world
This study is for people with
Lupus
Systemic lupus erythematosus
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy